EZH2 as a prognostic-related biomarker in lung adenocarcinoma correlating with cell cycle and immune infiltrates

BACKGROUNDS: It has been observed that high levels of enhancer of zeste homolog 2 (EZH2) expression are associated with unsatisfactory prognoses and can be found in a wide range of malignancies. However, the effects of EZH2 on Lung Adenocarcinoma (LUAD) remain elusive. Through the integration of bio...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Kui, Zhang, Bo-hui, Han, Deng, Sun, Yun-chuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10111667/
https://www.ncbi.nlm.nih.gov/pubmed/37069494
http://dx.doi.org/10.1186/s12859-023-05271-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10111667/
https://www.ncbi.nlm.nih.gov/pubmed/37069494
http://dx.doi.org/10.1186/s12859-023-05271-7

Ejemplares similares